guidelines

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that transvenous phrenic nerve stimulation (TPNS) – the treatment currently available only by the ZOLL remedē® System – is now included in the updated American Academy of Sleep Medicine (AASM) guidelines for treatment of central sleep apnea (CSA). The AASM recognizes the patient benefits of TPNS, highlighting the improvements in central event indice

LOS ANGELES--(BUSINESS WIRE)--The John Ritter Foundation for Aortic Health unveils updated “Ritter Rules” to save lives from aortic dissection.

(NASDAQ:ESPR) – Bempedoic Acid Receives Strongest Endorsement from ESC/EAS Guidelines Based on Compelling and Practice-Changing Evidence –

Updated guideline based on the latest evidence-based recommendations ROSEMONT, Ill., Aug. 28, 2025 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) issued an updated Clinical Practice Guideline (CPG) for the Management of Rotator Cuff Injuries, replacing the previous...

Allschwil, Switzerland & Radnor, Pennsylvania – August 19, 2025 Idorsia Ltd (SIX: IDIA) announces that its novel dual endothelin receptor antagonist (ERA), TRYVIO™ (aprocitentan), has been included in the new comprehensive clinical practice guidelines for the management of systemic hypertension, published by the American College of Cardiology (ACC) and the American Heart Association (AHA) Joint Committee. The updated recommendations now list TRYVIO as a therapy that may be added for adults with difficult-to-control hypertension, including resistant hypertension. TRYVIO is the first systemic hypertension treatment to target a new pathway in over 30 years and the only new medicine to be included in the updated guidelines.